Clinical Trial Update: High-intensity Rosuvastatin and Moderate-intensity Rosuvastatin/Ezetimibe in ASCVD Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing high-intensity rosuvastatin to moderate-intensity rosuvastatin/ezetimibe in patients with atherosclerotic cardiovascular disease has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease

Drugs mentioned

• Rosuvastatin (rosuvastatin)
• Rosuvastatin/Ezetimibe (rosuvastatin; ezetimibe)

Snippet

Sponsor: Yuhan Corporation | Conditions: ASCVD | Phase 4 | Status: COMPLETED